PostEra

Machine Learning for Drug Discovery. PostEra is building a modern 21st century biopharma. We use Proton, our AI platform for medicinal chemistry, to accelerate the discovery of new cures for patients. PostEra is advancing an internal pipeline while also advancing small molecule programs through partnerships with biopharma. We've closed over $1Bn in AI partnerships including 4 multi-year agreements with Pfizer and Amgen. PostEra is also leading an antiviral drug discovery center for pandemic preparedness, funded by one of the largest grants in NIH history